300759 康龙化成
交易中 06-18 13:04:33
资讯
新帖
简况
股市必读：康龙化成（300759）6月17日董秘有最新回复
证券之星 · 01:13
股市必读：康龙化成（300759）6月17日董秘有最新回复
康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，6月16日股价下跌2.14%
证券之星 · 06-16 17:40
康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，6月16日股价下跌2.14%
康龙化成：Boliang Lou博士当选董事长兼首席执行官
财中社 · 06-15 19:11
康龙化成：Boliang Lou博士当选董事长兼首席执行官
康龙化成(03759)将于8月7日派发末期现金股息每10股2.299274港元
智通财经 · 06-12
康龙化成(03759)将于8月7日派发末期现金股息每10股2.299274港元
康龙化成(03759)委任楼柏良为第四届董事会执行董事
智通财经 · 06-12
康龙化成(03759)委任楼柏良为第四届董事会执行董事
康龙化成：实控人楼小强补充质押400万股，累计质押57.77%持股
财中社 · 06-10
康龙化成：实控人楼小强补充质押400万股，累计质押57.77%持股
康龙化成(03759)选举李承宗为职工代表董事
智通财经 · 06-05
康龙化成(03759)选举李承宗为职工代表董事
康龙化成：公司经营正常有序，不存在应披露而未披露的重大事项
证券之星 · 06-05
康龙化成：公司经营正常有序，不存在应披露而未披露的重大事项
康龙化成获Ariel Investments, LLC增持53.34万股 每股作价约18.16港元
新浪港股 · 06-01
康龙化成获Ariel Investments, LLC增持53.34万股 每股作价约18.16港元
Ariel Investments, LLC增持康龙化成(03759)53.34万股 每股作价约18.16港元
智通财经 · 05-29
Ariel Investments, LLC增持康龙化成(03759)53.34万股 每股作价约18.16港元
新华健康丨康龙化成拟新建年产200吨医药中间体及API项目
经济参考网 · 05-28
新华健康丨康龙化成拟新建年产200吨医药中间体及API项目
康龙化成拟50亿元扩张产能，底气何在？
21世纪经济报道 · 05-28
康龙化成拟50亿元扩张产能，底气何在？
公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务
格隆汇 · 05-27
公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务
康龙化成：拟投资30亿元建年产200吨医药中间体项目 分期至2030年完成
财中社 · 05-27
康龙化成：拟投资30亿元建年产200吨医药中间体项目 分期至2030年完成
康龙化成最新公告：拟投资20亿元在杭州建设新药商业化生产和CDMO研发生产服务基地
证券之星 · 05-27
康龙化成最新公告：拟投资20亿元在杭州建设新药商业化生产和CDMO研发生产服务基地
康龙化成追加2.83亿元投资宁波甬康，累计认缴出资额达4.33亿元
财中社 · 05-22
康龙化成追加2.83亿元投资宁波甬康，累计认缴出资额达4.33亿元
Ariel Investments, LLC增持康龙化成(03759)90.07万股 每股作价约18.28港元
智通财经 · 05-21
Ariel Investments, LLC增持康龙化成(03759)90.07万股 每股作价约18.28港元
康龙化成(03759)将于8月7日派发末期股息每股0.2元
智通财经 · 05-21
康龙化成(03759)将于8月7日派发末期股息每股0.2元
Norges Bank增持康龙化成(03759)25.45万股 每股作价约18.71港元
智通财经 · 05-19
Norges Bank增持康龙化成(03759)25.45万股 每股作价约18.71港元
上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察
南方财经网 · 05-15
上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察
暂无数据
公司概况
公司名称：
康龙化成(北京)新药技术股份有限公司
所属行业：
研究和试验发展
上市日期：
2019-01-28
主营业务：
康龙化成(北京)新药技术股份有限公司的主营业务是提供从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要产品是实验室服务、CMC（小分子CDMO）服务、临床研究服务、大分子和细胞与基因治疗服务。
发行价格：
7.66
{"stockData":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":22.77,"timestamp":1781759073000,"preClose":22.17,"halted":0,"volume":28990295,"delay":0,"changeRate":0.0271,"floatShares":1420000000,"shares":1837000000,"eps":0.9219,"marketStatus":"交易中","change":0.6,"latestTime":"06-18 13:04:33","open":22.02,"high":22.94,"low":21.86,"amount":652000000,"amplitude":0.0487,"askPrice":22.77,"askSize":26,"bidPrice":22.76,"bidSize":46,"shortable":0,"etf":0,"ttmEps":0.9219,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781766000000},"marketStatusCode":2,"adr":0,"adjPreClose":22.17,"symbolType":"stock","openAndCloseTimeList":[[1781746200000,1781753400000],[1781758800000,1781766000000]],"highLimit":24.39,"lowLimit":19.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1837283628,"isCdr":false,"pbRate":2.47,"roa":"--","peRate":24.698991,"roe":"2.1%","epsLYR":0.9443,"committee":0.071672,"marketValue":41835000000,"turnoverRate":0.0204,"status":0,"hkstockBrief":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":15.25,"timestamp":1781759060000,"preClose":15.05,"halted":0,"volume":2344800,"delay":0,"premium":"-42.20"},"floatMarketCap":32334000000},"requestUrl":"/m/hq/s/300759/tweets","defaultTab":"tweets","newsList":[{"id":"2644282387","title":"股市必读：康龙化成（300759）6月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644282387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644282387?lang=zh_cn&edition=full","pubTime":"2026-06-18 01:13","pubTimestamp":1781716388,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，康龙化成报收于22.17元，上涨0.82%，换手率1.75%，成交量24.89万手，成交额5.51亿元。董秘最新回复投资者： 请公司尽快自愿性披露半年报预告，以提振市场信心！当日关注点交易信息汇总：6月17日主力资金净流出3632.47万元，游资资金净流出1174.72万元，散户资金净流入4807.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","BK1141","300759","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643097758","title":"康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，6月16日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643097758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643097758?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:40","pubTimestamp":1781602826,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，康龙化成报收于21.99元，较前一交易日下跌2.14%，最新总市值为404.02亿元。康龙化成（北京）新药技术股份有限公司于近日收到持股5%以上股东信中康成及其一致行动人信中龙成出具的《股份减持进展告知函》。2025年12月20日至2026年6月15日期间，二者合计减持公司10,668,077股股份，其中信中康成通过大宗交易减持4,379,977股，信中龙成通过集中竞价交易减持6,288,100股。本次权益变动后，合计持股比例由12.96%降至11.96%，变动达1%整数倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600031787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK1141","BK0216","03759","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643083842","title":"康龙化成：Boliang Lou博士当选董事长兼首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2643083842","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643083842?lang=zh_cn&edition=full","pubTime":"2026-06-15 19:11","pubTimestamp":1781521860,"startTime":"0","endTime":"0","summary":"6月15日，康龙化成（300759/03759）发布公告，公司完成了第四届董事会的换届选举，并聘任了新的高级管理人员和证券事务代表。新董事会成员包括执行董事BoliangLou博士（董事长）、楼小强、郑北、职工代表董事李承宗、非执行董事万璇及独立非执行董事李丽华、曾劲峰和沈蓉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606153771710033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","300759","03759","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295159","title":"康龙化成(03759)将于8月7日派发末期现金股息每10股2.299274港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295159?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:30","pubTimestamp":1781271024,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，将于2026年8月7日派发截至2025年12月31日止年度的末期现金股息每10股2.299274港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","BK4588","VIG","300759","EWH","BK0216","BK1576","BK1141","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642956902","title":"康龙化成(03759)委任楼柏良为第四届董事会执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2642956902","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642956902?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:24","pubTimestamp":1781270652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，于年度股东会上，经与会股东选举，决议批准委任楼柏良博士、楼小强先生及郑北女士为第四届董事会执行董事，委任万璇女士为第四届董事会非执行董事，及委任李丽华女士、曾劲峰教授及沈蓉女士为第四届董事会独立非执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03759","BK0216","BK1141","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642449356","title":"康龙化成：实控人楼小强补充质押400万股，累计质押57.77%持股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642449356","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642449356?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:21","pubTimestamp":1781079660,"startTime":"0","endTime":"0","summary":"6月10日，康龙化成（300759/03759）发布公告，实际控制人之一楼小强将其持有的400万股进行补充质押，占其所持股份的6.61%及公司总股本的0.22%。截至公告披露日，楼小强累计质押股份数量为3497万股，占其持股总数的57.77%及公司总股本的1.90%。2026年一季度，康龙化成实现收入35.78亿元，归母净利润3.35亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606103766690527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03759","BK1576","300759","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641214116","title":"康龙化成(03759)选举李承宗为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2641214116","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641214116?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:03","pubTimestamp":1780650197,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，本公司于2026年6月5日召开职工代表大会，并于会上选举李承宗先生为第四届董事会职工代表董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","300759","BK0216","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641659118","title":"康龙化成：公司经营正常有序，不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2641659118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641659118?lang=zh_cn&edition=full","pubTime":"2026-06-05 15:18","pubTimestamp":1780643904,"startTime":"0","endTime":"0","summary":"证券之星消息，康龙化成(300759)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价已连续下跌5年，相对于最高价已经跌去80%。请问：（1）公司经营是否出现重大变故？（2）是否有未披露的利空？（3）基于什么理由认为公司不会退市？”康龙化成回复：尊敬的投资者您好，公司经营正常有序，不存在应披露而未披露的重大事项。股价波动受宏观经济环境、政策因素、资本市场情绪等多重因素影响，敬请投资者注意投资风险。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500020524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK1576","BK0216","03759","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640898960","title":"康龙化成获Ariel Investments, LLC增持53.34万股 每股作价约18.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640898960","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640898960?lang=zh_cn&edition=full","pubTime":"2026-06-01 07:26","pubTimestamp":1780269960,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，5月26日，Ariel Investments， LLC增持康龙化成（03759）53.34万股，每股作价18.1646港元，总金额约为968.9万港元。增持后最新持股数目为2130.67万股，最新持股比例为6.04%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-06-01/doc-inhzwcks5473172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","03759","BK1576","EWH","300759","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639275256","title":"Ariel Investments, LLC增持康龙化成(03759)53.34万股 每股作价约18.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639275256","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639275256?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:22","pubTimestamp":1780057370,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月26日，Ariel Investments, LLC增持康龙化成(03759)53.34万股，每股作价18.1646港元，总金额约为968.9万港元。增持后最新持股数目为2130.67万股，最新持股比例为6.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","300759","BK1141","BK0216","03759","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638695348","title":"新华健康丨康龙化成拟新建年产200吨医药中间体及API项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2638695348","media":"经济参考网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638695348?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:39","pubTimestamp":1779971975,"startTime":"0","endTime":"0","summary":"康龙化成(北京)新药技术股份有限公司（简称“康龙化成”，300759.SZ，03759.HK）5月27日晚间发布公告，公司拟通过全资子公司在绍兴上虞经开区投资30亿元(人民币，下同)，建设年产200吨医药中间体及API（ActivePharmaceuticalIngredient，简称“API”，即原料药）项目，项目分两期落地投产，将聚焦肥胖症、糖尿病、肿瘤等高端药物原料生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752983239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300759","BK0216","03759","BK1576","BK1574","BK1161","BK1141","BK1515","159938","09939"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2638668844","title":"康龙化成拟50亿元扩张产能，底气何在？","url":"https://stock-news.laohu8.com/highlight/detail?id=2638668844","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638668844?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:09","pubTimestamp":1779952140,"startTime":"0","endTime":"0","summary":"国内CRO头部企业康龙化成（300759.SZ/3759.HK），同日披露两项重磅产能扩张计划，预计投资总规模将达50亿元。5月27日晚，康龙化成发布公告称，公司计划通过全资子公司康龙化成（绍兴）新药生产有限公司，斥资30亿元在绍兴市上虞区杭州湾上虞经济技术开发区内建设年产200吨医药中间体及API项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605283752721556.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752721556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","03759","300759","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638689303","title":"公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2638689303","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638689303?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:33","pubTimestamp":1779892385,"startTime":"0","endTime":"0","summary":"龙芯中科：拟定增募资不超23亿元","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4950239","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0236","BK0102","BK4139","BK4211","03759","000509","BK1141","300759","BK0145","BK1576","CDMO","PCB","BK0216","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638020165","title":"康龙化成：拟投资30亿元建年产200吨医药中间体项目 分期至2030年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2638020165","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638020165?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:31","pubTimestamp":1779881460,"startTime":"0","endTime":"0","summary":"5月27日，康龙化成（300759/03759）发布公告，公司计划通过全资子公司康龙化成（绍兴）新药生产有限公司，在绍兴市上虞区投资建设年产200吨医药中间体及API项目。项目的总投资金额为30亿元，旨在扩大高端医药中间体及原料药的产能规模，强化绿色制造技术的应用能力，并提升公司的CDMO服务能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605273751465310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","BK0216","BK1576","03759","BK1515","BK1141","300759","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638502392","title":"康龙化成最新公告：拟投资20亿元在杭州建设新药商业化生产和CDMO研发生产服务基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2638502392","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638502392?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:21","pubTimestamp":1779880875,"startTime":"0","endTime":"0","summary":"康龙化成(300759.SZ)公告称，公司拟在杭州市钱塘区投资约20亿元新建新药商业化生产和CDMO研发生产服务基地，并于2026年5月27日与杭州市钱塘区招商服务中心签订《投资协议》。项目预计2029年投入使用，旨在提升小分子药物和新型分子药物商业化生产及CDMO研发生产服务能力，支持项目管线向后期临床和商业化阶段转化。项目尚处筹备阶段，存在不确定性风险。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700040247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","300759","BK1576","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312650","title":"康龙化成追加2.83亿元投资宁波甬康，累计认缴出资额达4.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312650","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637312650?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:58","pubTimestamp":1779454680,"startTime":"0","endTime":"0","summary":"5月22日，康龙化成（300759/03759）发布公告，公司以自有资金向宁波甬康追加投资2.83亿元参与本次扩募。本次追加投资完成后，公司对宁波甬康认缴出资额共计4.33亿元。本次追加投资完成后，基金合伙人及认缴出资情况如下：2026年一季度，康龙化成实现收入35.78亿元，归母净利润3.35亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605223747008786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK0216","03759","BK1141","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637527338","title":"Ariel Investments, LLC增持康龙化成(03759)90.07万股 每股作价约18.28港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637527338","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637527338?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:05","pubTimestamp":1779361549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月18日，Ariel Investments, LLC增持康龙化成(03759)90.07万股，每股作价18.2754港元，总金额约为1646.07万港元。增持后最新持股数目为1778.99万股，最新持股比例为5.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","BK1576","BK0216","BK1141","300759","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637386759","title":"康龙化成(03759)将于8月7日派发末期股息每股0.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637386759","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637386759?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:11","pubTimestamp":1779354662,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)公布，将于2026年8月7日派发末期股息每股0.2元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03759","BK1576","300759","BK0216","VIG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636856330","title":"Norges Bank增持康龙化成(03759)25.45万股 每股作价约18.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636856330","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636856330?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:48","pubTimestamp":1779191309,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月15日，Norges Bank增持康龙化成(03759)25.45万股，每股作价18.707港元，总金额约为476.09万港元。增持后最新持股数目约为2493.17万股，最新持股比例为7.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","BK0216","300759","03759","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778885","title":"上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778885","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635778885?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:49","pubTimestamp":1778806140,"startTime":"0","endTime":"0","summary":"南方财经5月15日电，南财投研数据显示，5月14日，券商给予上市公司目标价共37次，按最新收盘价计算，目标价涨幅排名居前的公司有上汽集团、康龙化成、立昂微，目标价涨幅分别为61.67%、51.58%、49.37%，分别属于乘用车、医疗服务、半导体行业。评级调低方面，5月14日，券商调低上市公司评级达到1家次，国投证券对生物股份的评级从“买入”调低至“增持”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605153738144473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300759","600201","03759","600104"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781759076153,"stockEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":-0.1583},{"period":"3month","weight":-0.174},{"period":"6month","weight":-0.2469},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.2202}],"compareEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0057},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0559},{"period":"1year","weight":0.2128},{"period":"ytd","weight":0.0351}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康龙化成(北京)新药技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2019-01-28","address":"北京市大兴区北京经济技术开发区泰河路6号1幢八层","registeredCapital":"183728万元","survey":" 康龙化成(北京)新药技术股份有限公司的主营业务是提供从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要产品是实验室服务、CMC（小分子CDMO）服务、临床研究服务、大分子和细胞与基因治疗服务。","listedPrice":7.66},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,300759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}